Canavero S, Bonicalzi V
Turin Advanced Neuromodulation Group (Tang), Cso Einaudi 2, 10128 Torino, Italy.
Expert Rev Neurother. 2007 Nov;7(11):1485-97. doi: 10.1586/14737175.7.11.1485.
Central pain (CP), namely, pain or allied symptoms that follow damage to the CNS, has remained an obscure neurological syndrome with no explanation or effective treatment since Edinger's description in 1891. Once believed to be rare, CP is now known to affect several millions of people worldwide, making it at least as frequent as, for example, Parkinson's disease. It follows such common entities as stroke, spinal cord injury and multiple sclerosis, but also many other conditions, including neurosurgical procedures on the brain and spine. A disturbance of thalamocortical transmission is now acknowledged to be the main engine of CP. When drugs fail, neuromodulation, both electrical and chemical, provide relief to many drug nonresponders. A small stereotactic lesion deep in the subparietal white matter promises complete relief, without the ravages of neuroablation as performed widely in the past.
中枢性疼痛(CP),即中枢神经系统(CNS)受损后出现的疼痛或相关症状,自1891年埃丁格描述以来,一直是一种不明原因的神经综合征,没有有效的治疗方法。CP曾被认为很罕见,现在已知全球有数百万人受其影响,其发病率至少与帕金森病相当。它继发于中风、脊髓损伤和多发性硬化等常见疾病,但也继发于许多其他病症,包括脑部和脊柱的神经外科手术。丘脑皮质传递障碍现在被认为是CP的主要病因。当药物治疗无效时,电刺激和化学刺激等神经调节方法能为许多药物治疗无效的患者缓解症状。顶叶下白质深部的一个小立体定向损伤有望实现完全缓解,而不会像过去广泛实施的那样造成神经消融的破坏。